Medical devices approvals, launches, accreditations

Vanta implantable neurostimulator

Medtronic plc received U.S. Food and Drug Administration (FDA) approval for Vanta, a high-performance recharge-free implantable neurostimulator (INS) with a device life of up to 11 years. It uses Medtronic’s AdaptiveStim technology for personalized pain relief that adapts to the patient’s movement or body position using a built-in accelerometer. AdaptiveStim technology automatically adjusts stimulation to maintain each patient’s optimal dose. The Vanta neurostimulator also provides full-body magnetic resonance imaging (MRI) access with Medtronic SureScan technology.

The Vanta neurostimulator represents a 10% increase in longevity compared to PrimeAdvanced, Medtronic’s previous generation recharge-free device, while also being 20% smaller with a more rounded, ergonomic contouring for enhanced comfort. https://www.medtronic.com

Articulating instruments for Senhance Surgical System

Asensus Surgical Inc., a medical device company digitizing the interface between the surgeon and patient for a new era of Performance-Guided Surgery, received FDA 510(k) clearance for 5mm diameter articulating instruments, adding to the Senhance Surgical System technology platform. Articulating instruments increase access to difficult-to-reach areas of the anatomy by providing two additional degrees of freedom. These instruments have previously received CE Mark for use in the European Union.